Australia is welcome innovative treatment for excess weight: Retatrutide. This new dual molecule – targeting on both GLP-1 and GIP receptors – shows promising outcomes in international studies, pointing to substantial drops in BMI. While approval hasn't occurred with TGA, several individuals deal